When was AUM Cardio founded?

AUM Cardio was founded in 2009 and raised its 1st funding round within a year of its incorporation.

Where is AUM Cardio located?

AUM Cardio is headquartered in Northfield, United States.

How many employees does AUM Cardio have?

As of Jun 30, 2026, the latest employee count at AUM Cardio is 2.

Is AUM Cardio a funded company?

AUM Cardio is a funded company, having raised a total of $11.1M across 8 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2009.

When was the latest funding round of AUM Cardio?

AUM Cardio's latest funding was a $***** Series B round on Dec 14, 2016, with participation from 0 investor.

Where does AUM Cardio rank among its competitors?

AUM Cardio ranks 7th amongst 28 active competitors, of which 7 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Ionetix, which secured $30M in Feb, 2026.

Who are the top competitors of AUM Cardio?

AUM Cardio's top competitors include Conavi, Ionetix and Acarix. Among them, Ionetix secured the most recent funding round in February, 2026.

AUM Cardio - 2026 Company Profile, Team, Funding & Competitors

AUM Cardio is a series B company based in Northfield (United States), founded in 2009. It operates as a Device to detect coronary artery blockage. AUM Cardio has raised $11.1M in funding. The company has 28 active competitors, including 7 funded and 4 that have exited. Its top competitors include companies like Conavi, Ionetix and Acarix.

Company Details

AUM Cardiovascular, a medical device company, focuses on developing a technology to detect heart blockages. It develops CADence, a handheld device that detects blockages in the blood vessels around the heart to determine whether someone is developing heart disease or may be at risk for a sudden heart attack. CADence, is designed to detect functionally significant coronary blockage through a non-invasive, radiation-free test.

Website: aumcardio.com
Social

Key Metrics

Founded Year

2009

Location

Northfield, United States

Stage

Series B

Total Funding

$11.1M in 8 rounds

Latest Funding Round

Series B, Dec 14, 2016, $*****

Ranked

7^th among 28 active competitors

Employee Count

2 as on Jun 30, 2026

Similar Companies

Conavi & 39 more

View AUM Cardio's full profile

AUM Cardio has raised a total funding of $11.1M over 8 rounds. Its first funding round was on 2009.

Here is the list of recent funding rounds of AUM Cardio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 14, 2016	2906081	Series B	5057948	5826053	2901935	3696447
Jul 09, 2015	7399210	Series B	1220348	9614791	7045938	3557934
Jul 15, 2013	7240440	Series A	2016614	8364286	2622551	6852529

Access funding benchmarks and valuations. Sign up today!

View details of AUM Cardio's funding rounds and investors

AUM Cardio's employee count trend

AUM Cardio has 2 employees as of Jun 26. Here is AUM Cardio's employee count trend over the years:

Uncover AUM Cardio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AUM Cardio include Conavi, Ionetix and Acarix. Here is the list of Top 10 competitors of AUM Cardio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Conavi 2007, Toronto (Canada), Public	A catheter-based ultrasound system for cardiac imaging	$27.7M	FedDev Ontario, MaRS Discovery District & 5 others	66/100
2nd	Ionetix 2009, San Francisco (United States), Series C	Radiopharmaceutical solutions provider specializing in cyclotron technology and targeted alpha therapy	$61.1M	Lilly, Riverland Capital & 1 others	56/100
3rd	Acarix 2009, Kongens Lyngby (Denmark), Public	Provider of a screening device for acoustic coronary artery diseases	$9.97M	Sunstone, Seventure Partners & 3 others	49/100
4th	Infraredx 1998, Burlington (United States), Acquired	Intravascular imaging pioneers improving coronary artery disease treatment and patient outcomes	$101M	Sanderling Ventures, GE Healthcare Equipment Finance ... & 2 others	48/100
5th	Kaminari Medical 2018, Rotterdam (Netherlands), Series A	Developer of diagnostic solution for vulnerable plaque in the coronary arteries	$4.16M	Libertatis Ergo Holding, Graduate Ventures ... & 5 others	36/100
6th	GlyCardial Diagnostics 2017, Barcelona (Spain), Series A	In vitro diagnostic for myocardial ischemia	$2.8M	Ship2B, GENESIS Biomed & 5 others	34/100
7th	AUM Cardio 2009, Northfield (United States), Series B	Device to detect coronary artery blockage	$11.1M	-	33/100
8th	Ischemia Technologies 1997, Waltham (United States), Deadpooled	Develops, manufactures, and markets in vitro diagnostic tests for cardiac ischemia	$12.7M	GlidePath Partners, KB Partners & 3 others	31/100
9th	CPR Wrap 2015, Chattanooga (United States), Seed	Provider of CPR wrap tool for cardiac patients	-	Techstars, The Company Lab & 1 others	31/100
10th	POINT Biomedical 1996, San Carlos (United States), Deadpooled	Domain name pointbio.com is for sale via Sedo Domain Parking	$56.4M	Saints Capital, Invesco & 13 others	31/100